CD274 and neoplasm: Although the αCD25-m2a treatment alleviated tumor suppression by Treg depletion, the αPD-L1 treatment is known to block PD-L1 ligation to PD-1 on activated T cells, which circumvents the impairment of the T cell function [35,36].